Eldecalcitol is a synthetic vitamin D analog and calcitriol derivative primarily prescribed to treat osteoporosis by increasing lumbar and hip bone mineral density. As a potent inhibitor of bone resorption,… Read more


















































Eldecalcitol is a synthetic vitamin D analog and calcitriol derivative primarily prescribed to treat osteoporosis by increasing lumbar and hip bone mineral density. As a potent inhibitor of bone resorption, it functions by mimicking the physiological effects of 1,25-dihydroxyvitamin D3 in the body. This category provides essential materials for the rigorous analysis of this therapeutic agent, including certified reference standards of the active ingredient, its process-related impurities, potential metabolites, and stereoisomers. Pharmaceutical laboratories utilize these high-quality compounds for comprehensive impurity profiling, method validation, and ongoing quality control assessments. Furthermore, stable isotope-labelled Eldecalcitol standards are available to serve as reliable internal standards, facilitating accurate quantification and precise mass spectrometry analysis during the development and stability testing of pharmaceutical products.